Skip to content

Examination of change about comprehensive functional assessment before and while chemotherapy for pancreatic cancer in elderly patients using Cancer-Specific Geriatric Assessment(CSGA)

Examination of change about comprehensive functional assessment before and while chemotherapy for pancreatic cancer in elderly patients using Cancer-Specific Geriatric Assessment(CSGA) - A prospective study of functional assessments by CSGA for elderly pancreatic cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010666
Enrollment
50
Registered
2013-05-08
Start date
2013-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Sponsors

Department of Medical Oncology. kyorin University Faculty of Medicine,
Lead Sponsor
Kagoshima University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with pancreatic cancer that is diagnosed adenocarcinoma was confirmed histologically 2) Patients aged 70 years or older at the first chemotherapy 3) Patients of 0-2 Performance Status in ECOG 4) Patients expected to be capable of surviving at least 3 months

Exclusion criteria

Exclusion criteria: 1)Cases with moderate to severe delirium and dementia at the time of initial diagnosis and not expected help from caregivers and/or family surrounding 2)Patients impossible for evaluation by CSGA because of the merger of significant psychiatric and neurological disorders 3)Patients that attending doctors judge to be inappropriate to perform this study safely

Design outcomes

Primary

MeasureTime frame
Relation to overall survival(OS) and scores of comprehensive geriatric assessments by CSGA

Secondary

MeasureTime frame
Relation to the scores of comprehensive geriatric assessments by CSGA and as follows; Progression-free survival(PFS), Time to treatment failure of primary treatment(TTF), Non-hospital stay, Adverse events rate

Countries

Japan

Contacts

Public ContactInstitute of Medical ethics Kyorin University, Faculty of Medicine

Kyorin University School of Medecine Department of Internal Medicine, Medical Oncology

info@ks.kyorin-u.ac.jp0422-47-5511(3220)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026